Latest news with #daVinci
Gulf Today
17 hours ago
- Health
- Gulf Today
Dubai hospital performs 825 robotic surgeries
Clemenceau Medical Center Dubai (CMC Dubai), has performed over 825 robotic procedures in last four years using the state-of-the-art da Vinci surgical system. CMC Dubai celebrated the achievement recently at the hospital's Dubai campus, attended by hospital leadership, surgeons, and the da Vinci robotic surgical team. Mark Adams, CEO, Clemenceau Medical Center Dubai said, 'Dubai is the city of innovation with the vision of the future. Every day, there is innovation with new developments — and in CMC, we want to be in front of that. In 2021, we introduced robotic surgery, and in the last four years, we have performed 825 robotic surgeries, which makes CMC one of the most advanced hospitals.' The hospital continues to redefine surgical excellence through the advanced integration of robotic technology across multiple specialties. As a regional leader in medical innovation, CMC Dubai has successfully deployed robotic-assisted surgery in general surgery, gynecology, urology, bariatric surgery, and more recently, orthopedics—demonstrating a truly multidisciplinary approach to precision care. 'Robotic surgery offers unmatched precision and control, allowing us to minimize complications and ensure faster patient recovery,' said Dr Walid Faraj, Consultant General Surgeon at CMC Dubai. 'The robotic system doesn't replace the surgeon — it enhances our capabilities. With 360-degree articulation and exceptional accuracy, we're able to operate in areas that would be challenging or risky using traditional techniques.' 'Robotic surgery is no longer the future — it's the present, empowering surgeons to perform safer, faster, and more accurate procedures,' said Dr Abdul Kader Weiss, Specialist General & Laparoscopic Surgeon at CMC Dubai. 'What once required large incisions and long hospital stays can now be done through tiny ports, with the robot as an extension of the surgeon's hand. At CMC, we are proud to be at the forefront of this transformation, aligning with the UAE's ambition to lead in medical innovation.' The result is a transformative impact on both clinical outcomes and patient experience. Robotic-assisted procedures typically involve smaller incisions, reduced blood loss, less post-operative pain, and significantly shorter hospital stays. Many patients are discharged within 24 to 48 hours, returning to normal activities more quickly and with fewer complications. CMC Dubai was among the first hospitals in the UAE to adopt robotic surgery and continues to set benchmarks in this domain. The center's commitment to innovation is matched by its focus on patient safety, outcome-driven care, and ongoing investment in the latest surgical technologies. 'Our goal is to expand what is surgically possible,' added Dr. Faraj. 'With robotic systems, we are performing more complex surgeries with greater confidence and control, while continuously improving patient satisfaction and recovery time.'
Mid East Info
3 days ago
- Business
- Mid East Info
Clemenceau Medical Center Dubai Celebrates 825 Robotic Surgeries, Leading Innovation in Surgical Care - Middle East Business News and Information
Clemenceau Medical Center Dubai (CMC Dubai) continues to redefine surgical excellence through the advanced integration of robotic technology across multiple specialties. As a regional leader in medical innovation, CMC Dubai has successfully deployed robotic-assisted surgery in general surgery, gynecology, urology, bariatric surgery, and more recently, orthopedics—demonstrating a truly multidisciplinary approach to precision care. With over 825 robotic procedures performed using the state-of-the-art da Vinci Surgical System, CMC Dubai marks a major milestone in its journey toward transforming patient care. A celebration of this achievement will be held at 1:00 PM on Thursday, May 22, 2025, at the hospital's Dubai campus, attended by hospital leadership, surgeons, and the da Vinci robotic surgical team. 'Dubai is the city of innovation with the vision of the future. It helps the sociality. Every day, there is innovation with new developments—and in CMC, we want to be in front of that. In 2021, we introduced robotic surgery, and in the last four years, we have performed 825 robotic surgeries, which makes CMC one of the most advanced hospitals. I do not see the surgeon being replaced by the automatic system, but rather the system helps and guides the surgeon to perform with higher precision.' — Mr. Mark Adams, CEO, Clemenceau Medical Center Dubai 'Robotic surgery offers unmatched precision and control, allowing us to minimize complications and ensure faster patient recovery,' says Dr. Walid Faraj, Consultant General Surgeon at CMC Dubai. 'The robotic system doesn't replace the surgeon—it enhances our capabilities. With 360-degree articulation and exceptional accuracy, we're able to operate in areas that would be challenging or risky using traditional techniques.' 'Robotic surgery is no longer the future—it's the present, empowering surgeons to perform safer, faster, and more accurate procedures,' says Dr. Abdul Kader Weiss, Specialist General & Laparoscopic Surgeon at CMC Dubai. 'What once required large incisions and long hospital stays can now be done through tiny ports, with the robot as an extension of the surgeon's hand. At CMC, we are proud to be at the forefront of this transformation, aligning with the UAE's ambition to lead in medical innovation.' The result is a transformative impact on both clinical outcomes and patient experience. Robotic-assisted procedures typically involve smaller incisions, reduced blood loss, less post-operative pain, and significantly shorter hospital stays. Many patients are discharged within 24 to 48 hours, returning to normal activities more quickly and with fewer complications. Delivering Superior Outcomes Through Innovation CMC Dubai was among the first hospitals in the UAE to adopt robotic surgery and continues to set benchmarks in this domain. The center's commitment to innovation is matched by its focus on patient safety, outcome-driven care, and ongoing investment in the latest surgical technologies. 'Our goal is to expand what is surgically possible,' adds Dr. Faraj. 'With robotic systems, we are performing more complex surgeries with greater confidence and control, while continuously improving patient satisfaction and recovery time.' Backed by an international legacy of excellence and a strong vision for the future, Clemenceau Medical Center Dubai remains a leader in robotic surgery, not just within the UAE, but across the wider Middle East region. About Clemenceau Medical Center Dubai Clemenceau Medical Center Dubai is part of the Clemenceau Medicine International network, affiliated with Johns Hopkins Medicine International. With a mission to deliver world-class, patient-centered care using cutting-edge technology and internationally trained physicians, CMC Dubai is redefining healthcare standards in the region.
Hans India
4 days ago
- Health
- Hans India
Robotic-assisted surgery steadily transforming gynaecological care: Study
Bengaluru: A study released to coincide with Women's Health Month, is shedding light on how robotic-assisted surgery (RAS) is steadily transforming gynaecological care across the country. May month is observed as Women's Health Month worldwide, to focus on raising awareness about women's health issues and encouraging women to prioritise their physical, mental, and emotional well-being. 'Women's Health Month is a time to reflect on how surgical technology innovations like the da Vinci robotic technology are enhancing healthcare outcomes for women,' said Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City, Hyderabad, one of the surgeons who oversaw the study. The multi-institutional study, 'Trends in Gynaecological Robotic Surgery in India: A Real-World Scenario', was conducted across five tertiary care hospitals -- Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bengaluru), Narayana Health (Bengaluru), and Tata Memorial Hospital (Mumbai). It analysed the data of surgeries performed using the da Vinci technology over a decade. The study documents a significant rise in the use of robotic surgery for both benign and malignant conditions and is significant for its implications on access, recovery, and surgical outcomes for women. 'Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced precision and improved outcomes across a wide range of cases,' said Dr Sinha, who is also the Founder-President of Association of Gynecological Robotic Surgeons. According to her, over 70 per cent of robotic gynaecological procedures took place in the final five years, indicating a strong upward trajectory. 'We have seen that with robotic procedures, women often spend less time in the hospital and experience fewer complications related to blood loss,' said Dr Vanita Jain, Head of Obstetrics and Gynaecology at PGIMER, Chandigarh, who was also part of the study. She noted that it is not just about using new technology. 'It is about making recovery more manageable, especially for women who are balancing responsibilities at home and work,' added Dr Jain. The study found that fibroids were the most common benign indication for robotic surgery, followed by endometriosis, adenomyosis, vault prolapse, and ovarian cysts. These conditions, said the doctors, often require careful dissection and suturing, particularly when fertility preservation is important. 'Myomectomy, or the removal of fibroids while preserving the uterus, especially calls for such precision,' explained Dr Subhas C Saha, Professor, Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, another key facilitator of the study. 'Advanced robotic systems like the da Vinci platform offer us better visualisation and manoeuvrability, which can make a real difference in these challenging cases,' he added. While more public and private insurers are beginning to include robotic-assisted surgery (RAS) in their coverage, the study highlights that there is still room to improve affordability and access. To optimise value and accessibility, surgeons are refining techniques -- using fewer robotic arms and incorporating multifunctional instruments -- to reduce costs while still delivering high-quality care and better patient outcomes. 'Given the clear benefits demonstrated in studies like this, there is a strong case for insurance payers to further expand coverage for robotic-assisted surgery. Broader, streamlined reimbursement support can help ensure more women across India have access to advanced surgical options,' Dr Saha added.
&w=3840&q=100)
Business Standard
5 days ago
- Health
- Business Standard
Robotic-assisted surgery steadily transforming gynaecological care: study
A study released to coincide with Women's Health Month, is shedding light on how robotic-assisted surgery (RAS) is steadily transforming gynaecological care across the country. May month is observed as Women's Health Month worldwide, to focus on raising awareness about women's health issues and encouraging women to prioritise their physical, mental, and emotional well-being. "Women's Health Month is a time to reflect on how surgical technology innovations like the da Vinci robotic technology are enhancing healthcare outcomes for women," said Dr Rooma Sinha, Honorary Professor and Chief Gynaecologist at Apollo Health City, Hyderabad, one of the surgeons who oversaw the study. The multi-institutional study, 'Trends in Gynaecological Robotic Surgery in India: A Real-World Scenario', was conducted across five tertiary care hospitals -- Apollo Health City (Hyderabad), PGIMER (Chandigarh), Manipal Hospital (Bengaluru), Narayana Health (Bengaluru), and Tata Memorial Hospital (Mumbai). It analysed the data of surgeries performed using the da Vinci technology over a decade. The study documents a significant rise in the use of robotic surgery for both benign and malignant conditions and is significant for its implications on access, recovery, and surgical outcomes for women. "Robotic-assisted surgery is increasingly being used to manage benign gynaecological conditions such as fibroids and endometriosis, offering enhanced precision and improved outcomes across a wide range of cases," said Dr Sinha, who is also the Founder-President of Association of Gynecological Robotic Surgeons. According to her, over 70 per cent of robotic gynaecological procedures took place in the final five years, indicating a strong upward trajectory. "We have seen that with robotic procedures, women often spend less time in the hospital and experience fewer complications related to blood loss," said Dr Vanita Jain, Head of Obstetrics and Gynaecology at PGIMER, Chandigarh, who was also part of the study. She noted that it is not just about using new technology. "It is about making recovery more manageable, especially for women who are balancing responsibilities at home and work," added Dr Jain. The study found that fibroids were the most common benign indication for robotic surgery, followed by endometriosis, adenomyosis, vault prolapse, and ovarian cysts. These conditions, said the doctors, often require careful dissection and suturing, particularly when fertility preservation is important. "Myomectomy, or the removal of fibroids while preserving the uterus, especially calls for such precision," explained Dr Subhas C Saha, Professor, Department of Obstetrics and Gynaecology, PGIMER, Chandigarh, another key facilitator of the study. "Advanced robotic systems like the da Vinci platform offer us better visualisation and manoeuvrability, which can make a real difference in these challenging cases," he added. While more public and private insurers are beginning to include robotic-assisted surgery (RAS) in their coverage, the study highlights that there is still room to improve affordability and access. To optimise value and accessibility, surgeons are refining techniques -- using fewer robotic arms and incorporating multifunctional instruments -- to reduce costs while still delivering high-quality care and better patient outcomes. "Given the clear benefits demonstrated in studies like this, there is a strong case for insurance payers to further expand coverage for robotic-assisted surgery. Broader, streamlined reimbursement support can help ensure more women across India have access to advanced surgical options," Dr Saha added. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Yahoo
7 days ago
- Business
- Yahoo
3 Nasdaq 100 Stocks to Research Further
The Nasdaq 100 (^NDX) is packed with high-growth companies, and while the market is competitive, some are pulling ahead. A handful of standout businesses are continuing to scale, delivering strong financials and market leadership. Even among industry leaders, some companies shine bright, and we built StockStory to help you find them. That said, here are three Nasdaq 100 stocks that could lead the market. Market Cap: $119.9 billion Co-founded by Adam Foroughi, who was frustrated with not being able to find a good solution to market his own dating app, AppLovin (NASDAQ:APP) is both a mobile game studio and provider of marketing and monetization tools for mobile app developers. Why Does APP Catch Our Eye? Fast payback periods on sales and marketing expenses allow the company to invest heavily and onboard many customers concurrently Healthy operating margin of 42.8% shows it's a well-run company with efficient processes, and it turbocharged its profits by achieving some fixed cost leverage Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends AppLovin's stock price of $354.99 implies a valuation ratio of 20x forward price-to-sales. Is now the time to initiate a position? Find out in our full research report, it's free. Market Cap: $37.34 billion Originally serving yogis and hockey players, Lululemon (NASDAQ:LULU) is a designer, distributor, and retailer of athletic apparel for men and women. Why Do We Love LULU? Brick-and-mortar locations are witnessing elevated demand as their same-store sales growth averaged 8.2% over the past two years Collection of products is difficult to replicate at scale and leads to a best-in-class gross margin of 58.8% LULU is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders Lululemon is trading at $311 per share, or 20.2x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it's free. Market Cap: $193.4 billion Pioneering minimally invasive surgery since its first da Vinci system was FDA-cleared in 2000, Intuitive Surgical (NASDAQ:ISRG) develops and manufactures robotic-assisted surgical systems that enable minimally invasive procedures across various medical specialties. Why Is ISRG Interesting? Products are seeing elevated demand as its system placement averaged 11.8% growth over the past two years Sales outlook for the upcoming 12 months implies the business will stay on its desirable two-year growth trajectory Earnings growth has comfortably beaten the peer group average over the last five years as its EPS has compounded at 12.3% annually At $540 per share, Intuitive Surgical trades at 64.3x forward P/E. Is now the right time to buy? Find out in our full research report, it's free. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
